Graeme Bell to Cyclin-Dependent Kinase Inhibitor p16
This is a "connection" page, showing publications Graeme Bell has written about Cyclin-Dependent Kinase Inhibitor p16.
Transancestral fine-mapping of four type 2 diabetes susceptibility loci highlights potential causal regulatory mechanisms. Hum Mol Genet. 2016 05 15; 25(10):2070-2081.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.